Morten Ph D Luhr
About
Morten Ph D Luhr is from Oslo, Oslo, Norway. Morten works in the following industries: "Biotechnology Research". Morten is currently Scientific Alliance and Business Development Manager at PCI Biotech Holding ASA. In Morten's previous role as a Staff Scientist (Product Development) at Thermo Fisher Scientific, Morten worked in Oslo, Norway until Oct 2021. Prior to joining Thermo Fisher Scientific, Morten was a Referee (research funding for industry grants) at Norges forskningsråd and held the position of Referee (research funding for industry grants) at Norge. Prior to that, Morten was a Scientist III (Product Development) at Thermo Fisher Scientific, based in Oslo Area, Norway from Sep 2018 to Apr 2021. Morten started working as Ph.D. student at University of Oslo in Oslo Area, Norway in Aug 2014. From Nov 2017 to Apr 2018, Morten was Fulbright Scholar at Dana-Farber Cancer Institute, based in Greater Boston Area. Prior to that, Morten was a Fulbright Scholar at Harvard Medical School, based in Greater Boston Area from Nov 2017 to Apr 2018. Morten started working as Summer intern (HSEQ) at Eni Norge AS in Stavanger Area, Norway in Jun 2012.
You can find Morten Ph D Luhr's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Morten Ph D Luhr's current jobs
Morten Ph D Luhr's past jobs
Voted top 20 innovator among >5000 R&D scientists in Thermo Fisher. Lead scientist on disruptive product development projects in the cell therapy (CAR-T, TCR-T) medtech/manufacturing and automation space (cGMP and ISO 13485), including Beta prototype testing with top-tier customers. Co-inventor on a patent application (under review). Managed cross-functional (immunology, nanotechnology, engineering, industrial design, regulatory, quality) cross-continent (Europe, Asia, US) R&D projects, including business-to-business (B2B) collaborations. The common thread in all projects was customer focus, enabling customers making the world healthier.
Lead scientist on disruptive product development projects in the cell therapy (CAR-T, TCR-T) manufacturing/medtech and automation space (cGMP and ISO 13485), including Alpha prototype testing. Co-inventor on a patent application (under review). Managed cross-functional (immunology, nanotechnology, engineering, industrial design, regulatory, quality) cross-continent (Europe, Asia, US) R&D projects, including business-to-business (B2B) collaborations. The common thread in all projects was customer focus, enabling customers making the world healthier.
Engaged extensively in national and international research collaborations, including a 6 month research visit to Harvard University. Co-authored 12 scientific manuscripts, 11 of which have already been published in international peer-reviewed journals/books. Presented at 7 international conferences. Visiting researcher at Harvard Medical School (Dana-Farber Cancer Institute) for 6 months as a Fulbright Scholar, focussing og subcellular fractionation and proteomics. As a teaching assistant for 3 semesters, I coordinated a university course for 280 students, led the semester-long laboratory course for 280 students, including mentoring Ph.D. level and MSc level teaching staff. Undertook a course in entrepreneurship (Massachusetts Institute of Technology, MOOC) and project management (University of Adelaide, MOOC) in my spare time to acquire business-related skills. Initiated a monthly networking event to connect NCMM employees. Additionally, I was part of a committee that organised weekly scientific meetings at NCMM.
As a Fulbright Scholar, I conducted a 6-month research visit at Harvard Medical School/Dana-Farber Cancer Institute, in the laboratory of Dr. Joseph D. Mancias. I studied how resistance mechanisms, such as autophagy ("self-eating") and the unfolded protein response, affect how cancer cells are able to cope with stress and develop therapeutic resistance. Additionally, I led a method development project on proteomic analysis of organelles.
As a Fulbright Scholar, I conducted a 6-month research visit at Harvard Medical School/Dana-Farber Cancer Institute, in the laboratory of Dr. Joseph D. Mancias. I studied how resistance mechanisms, such as autophagy ("self-eating") and the unfolded protein response, affect how cancer cells are able to cope with stress and develop therapeutic resistance. Additionally, I led a method development project on proteomic analysis of organelles.
Prepared regulatory documents for getting Eni’s flagship Goliat platform approved for drilling in the Barents Sea.
Conducted colloquiums for first-year biology and biochemistry students.
Part-time job at Helse Vest Stavanger (Psychiatric Division).